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Background:  Rho kinase (ROCK) activation induces smooth muscle cell contraction and cardiovascular remodeling. We previously observed 
increased ROCK activity in hypertensive patients (HT) with left ventricular hypertrophy. However, ROCK activation in HT patients with diabetes (DMII) 
has not been evaluated. The aim was to compare levels of ROCK activity, oxidative stress and vascular remodeling in HT patients with and without 
DM II.
Methods:  In this cross sectional study ROCK activity was measured in a) HT patients (untreated), b) in hypertensive patients with DMII 
under treatment and c) in normotensive healthy individuals. ROCK activation was determined in circulating leukocytes by measuring the levels 
of phosphorylated/total myosin light chain phosphatase 1 (MYPT1, by western blot). Carotid to femoral pulse wave velocity (PWV), plasma 
malondyaldehyde (MDA) and 8-isoprostane levels (8-ISO) levels and left ventricular mass index (LVMI) by transthoracic echocardiography were also 
determined.
Results:  table, mean ± SEM
Symbols: * = p < 0.05 versus the other groups (after ANOVA)
abbreviations: MAP: mean arterial pressure, NS: not significant
Conclusions:  Rho kinase activity and oxidative stress parameters are increased in HT patients with DMII versus HT without DMII and similar LVMI. 
These findings are also related to impaired arterial distensibility and could explain in part, the pathological vascular remodeling of these patients. 
Fondecyt 1085208
Controls (n = 34) HT without DM (n = 38) HT with DM (n = 21) ANOVA (p)
Age (years) 52 ± 1.1 52 ± 1.1 51 ± 0.9 NS
Women (%) 52 50 47 NS
MAP (mmHg) 87 ± 1.2 121 ± 1.3 111 ± 1.9 * <0.01
MYPT1 (p/t) 2.1 ± 0.4 3.6 ± 0.4 5.6 ± 1.3 * <0.01
8-ISO (pg/mL) 4.5 ± 0.7 5.9 ± 0.8 41 ± 8.2* <0.01
MDA (μM) 0.4 ± 0.06 0.49 ± 0.08 1.8 ± 0.4* <0.01
PWV (m/seg) 8.1 ± 0.1 11 ± 0.4 14 ± 0.9 * <0.01
LVMI (gr/m2) 88 ± 3 * 108 ± 5 108 ± 6 <0.01
Glycemia (mg/dL) 91 ± 3 96 ± 3 150 ± 12 * <0.01
